These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

328 related items for PubMed ID: 393505

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Studies on the renin-angiotensin-aldosterone system in elderly hypertensive patients with an angiotensin II antagonist.
    Ogihara T, Hata T, Maruyama A, Mikami H, Nakamaru M, Mandai T, Kumahara Y.
    Clin Sci (Lond); 1979 Nov; 57(5):461-3. PubMed ID: 519955
    [Abstract] [Full Text] [Related]

  • 6. Effect of pressor agents on blood pressure, plasma renin activity and plasma aldosterone concentration in essential hypertension.
    Yamamoto Y.
    Jpn Heart J; 1975 Jul; 16(4):404-20. PubMed ID: 1152295
    [Abstract] [Full Text] [Related]

  • 7. Effects of two angiotensin II analogues on blood pressure, plasma aldosterone concentration, plasma renin activity and creatinine clearance in normal subjects on different sodium intakes.
    Hata T, Ogihara T, Mikami H, Nakamaru M, Mandai T, Kumahara Y.
    Eur J Clin Pharmacol; 1980 Oct; 18(4):295-9. PubMed ID: 7002566
    [Abstract] [Full Text] [Related]

  • 8. The effect of angiotensin II antagonist, Sar1-Ile8-angiotensin II, on furosemide-induced increase in plasma noradrenaline, renin activity and aldosterone in unanesthetized dogs.
    Ueno Y, Arita M, Suruda H, Ohtani H, Minakata T, Kuchii M, Nishio I, Masuyama Y.
    Jpn Circ J; 1980 Dec; 44(12):981-7. PubMed ID: 7003179
    [Abstract] [Full Text] [Related]

  • 9. [Comparison of effects of two angiotensin II antagonists on blood pressure, heart rate, plasma renin activity, and plasma aldosterone concentration in the same hypertensive patients].
    Higuma K, Fujishima S, Shionoiri H, Tochikubo O, Uneda S, Fujiki Y, Kaneko Y.
    Nihon Jinzo Gakkai Shi; 1984 Apr; 26(4):425-35. PubMed ID: 6381833
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Blood pressure response to an angiotensin II antagonist in thyrotoxic patients with and without high blood pressure.
    Ogihara T, Hata T, Maruyama A, Mikami H, Nakamaru M, Naka T, Kumahara Y, Kuma K.
    Endocrinol Jpn; 1980 Apr; 27(2):223-7. PubMed ID: 7408785
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Abnormal adrenal responsiveness and angiotensin II dependency in high renin essential hypertension.
    Dluhy RG, Bavli SZ, Leung FK, Solomon HS, Moore TJ, Hollenberg NK, Williams GH.
    J Clin Invest; 1979 Nov; 64(5):1270-6. PubMed ID: 500810
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.